Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Myqorzo (aficamten)
.
Show all posts
Showing posts with label
Myqorzo (aficamten)
.
Show all posts
Wednesday, July 22, 2026
FDA Approves Myqorzo (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
›
Cytokinetics, Incorporated (Nasdaq: CYTK) announced the U.S. Food and Drug Administration (FDA) approval of Myqorzo™ (aficamten, 5 mg, 10 m...
›
Home
View web version
